Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    January 2022
  1. DE MEL S, Mustafa N, Selvarajan V, Azaman MI, et al
    T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
    PLoS One. 2022;17:e0261469.
    PubMed     Abstract available


  2. HARVEY MJ, Zhong Y, Morris E, Beverage JN, et al
    Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
    PLoS One. 2022;17:e0261336.
    PubMed     Abstract available


  3. BROCCIA G, Carter J, Ozsin-Ozler C, Meloni F, et al
    Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy.
    PLoS One. 2022;17:e0260078.
    PubMed     Abstract available


  4. WORONIECKA R, Rymkiewicz G, Szafron LM, Blachnio K, et al
    Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
    PLoS One. 2022;17:e0263980.
    PubMed     Abstract available


  5. HOWELL DA, McCaughan D, Smith AG, Patmore R, et al
    Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
    PLoS One. 2022;17:e0263672.
    PubMed     Abstract available


  6. SU YC, Chiu BC, Li HJ, Yang WC, et al
    Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
    PLoS One. 2022;17:e0265543.
    PubMed     Abstract available


  7. GEORGI TW, Zieschank A, Kornrumpf K, Kurch L, et al
    Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
    PLoS One. 2022;17:e0267275.
    PubMed     Abstract available


  8. MALENGE MM, Maaland AF, Repetto-Llamazares A, Middleton B, et al
    Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.
    PLoS One. 2022;17:e0267543.
    PubMed     Abstract available


  9. GROS A, Menguy S, Bobee V, Ducharme O, et al
    Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling.
    PLoS One. 2022;17:e0266978.
    PubMed     Abstract available


  10. LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
    Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
    PLoS One. 2022;17:e0264634.
    PubMed     Abstract available


  11. KAWAHIRA M, Kanmura S, Mizuno K, Machida K, et al
    Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events.
    PLoS One. 2022;17:e0267572.
    PubMed     Abstract available


  12. TSUTSUE S, Makita S, Yi J, Crawford B, et al
    Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis.
    PLoS One. 2022;17:e0269169.
    PubMed     Abstract available


  13. OGISO A, Mizuno T, Ito K, Mizokami F, et al
    Use of benzodiazepines is the risk factor for infection in patients aged 80 years or older with diffuse large B-cell lymphoma: A single-institution retrospective study.
    PLoS One. 2022;17:e0269362.
    PubMed     Abstract available


  14. HAYAKAWA J, Seki T, Kawazoe Y, Ohe K, et al
    Pathway importance by graph convolutional network and Shapley additive explanations in gene expression phenotype of diffuse large B-cell lymphoma.
    PLoS One. 2022;17:e0269570.
    PubMed     Abstract available


    January 2021
  15. CREMASCO F, Menietti E, Speziale D, Sam J, et al
    Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNgamma/CXCL10-dependent peripheral T cell recruitment in humanized murine model.
    PLoS One. 2021;16:e0241091.
    PubMed     Abstract available


  16. NAGEL S, Pommerenke C, Meyer C, MacLeod RAF, et al
    Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.
    PLoS One. 2021;16:e0246603.
    PubMed     Abstract available


  17. GHOBADI MZ, Emamzadeh R, Mozhgani SH
    Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes.
    PLoS One. 2021;16:e0247713.
    PubMed     Abstract available


  18. KARAGIANNI F, Piperi C, Mpakou V, Spathis A, et al
    Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma.
    PLoS One. 2021;16:e0248298.
    PubMed     Abstract available


  19. GAIOLLA RD, Moraes MPT, de Oliveira DE
    SNPs in genes encoding for IL-10, TNF-alpha, and NFkappaB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.
    PLoS One. 2021;16:e0248259.
    PubMed     Abstract available


  20. MORIBE F, Nishikori M, Takashima T, Taniyama D, et al
    Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development.
    PLoS One. 2021;16:e0237554.
    PubMed     Abstract available


  21. HSU CH, Tomiyasu H, Liao CH, Lin CS, et al
    Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line.
    PLoS One. 2021;16:e0250013.
    PubMed     Abstract available


  22. SLOAN SL, Renaldo KA, Long M, Chung JH, et al
    Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma.
    PLoS One. 2021;16:e0250839.
    PubMed     Abstract available


  23. KE Q, Liao CC, Tan XH, Guo BP, et al
    Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma.
    PLoS One. 2021;16:e0252226.
    PubMed     Abstract available


  24. TAKASHIMA Y, Kawaguchi A, Fukai J, Iwadate Y, et al
    Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
    PLoS One. 2021;16:e0251272.
    PubMed     Abstract available


  25. FAUZI YR, Nakahata S, Chilmi S, Ichikawa T, et al
    Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    PLoS One. 2021;16:e0256320.
    PubMed     Abstract available


  26. VON BEEK C, Alriksson L, Palle J, Gustafson AM, et al
    Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
    PLoS One. 2021;16:e0256708.
    PubMed     Abstract available


  27. AMBROSE C, Su L, Wu L, Dufort FJ, et al
    Anti-CD19 CAR T cells potently redirected to kill solid tumor cells.
    PLoS One. 2021;16:e0247701.
    PubMed     Abstract available


  28. PETRENKO O, Li J, Cimica V, Mena-Taboada P, et al
    IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
    PLoS One. 2021;16:e0247394.
    PubMed     Abstract available


  29. MASLE-FARQUHAR E, Russell A, Li Y, Zhu F, et al
    Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice.
    PLoS One. 2021;16:e0237830.
    PubMed     Abstract available


  30. OTA Y, Yoda H, Inoue T, Watanabe T, et al
    Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
    PLoS One. 2021;16:e0257718.
    PubMed     Abstract available


  31. MOSQUERA ORGUEIRA A, Ferreiro Ferro R, Diaz Arias JA, Aliste Santos C, et al
    Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    PLoS One. 2021;16:e0248886.
    PubMed     Abstract available


  32. EVANGELISTA-LEITE D, Affonso Madaloso B, Shouta Yamashita B, Enrico Aloise F, et al
    Treating chronic diarrhea: A systematic review on Immunoproliferative Small Intestinal Disease (IPSID).
    PLoS One. 2021;16:e0253695.
    PubMed     Abstract available


  33. KIM RY, Park JH, Kim M, Park YG, et al
    Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
    PLoS One. 2021;16:e0260469.
    PubMed     Abstract available


  34. NAGEL S, Meyer C
    Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma.
    PLoS One. 2021;16:e0259674.
    PubMed     Abstract available


  35. PAIK H, Kim J
    Condensed trajectory of the temporal correlation of diseases and mortality extracted from over 300,000 patients in hospitals.
    PLoS One. 2021;16:e0257894.
    PubMed     Abstract available


  36. LIAO N, Koehne T, Tuckermann J, Triviai I, et al
    Osteoblast-specific inactivation of p53 results in locally increased bone formation.
    PLoS One. 2021;16:e0249894.
    PubMed     Abstract available


  37. BRAGA M, Leow CH, Gil JH, Teh JH, et al
    Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach.
    PLoS One. 2021;16:e0260186.
    PubMed     Abstract available


    January 2020
  38. GEORGI TW, Kurch L, Hasenclever D, Warbey VS, et al
    Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
    PLoS One. 2020;15:e0231027.
    PubMed     Abstract available


  39. LIU KL, Tsai WC, Lee CH
    Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.
    PLoS One. 2020;15:e0228046.
    PubMed     Abstract available


  40. KADIN ME, Hamilton RG, Vonderheid EC
    Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder.
    PLoS One. 2020;15:e0228751.
    PubMed     Abstract available


  41. MAESTRE L, Garcia-Garcia JF, Jimenez S, Reyes-Garcia AI, et al
    High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
    PLoS One. 2020;15:e0229743.
    PubMed     Abstract available


  42. MONRAD I, Madsen C, Lauridsen KL, Honore B, et al
    Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
    PLoS One. 2020;15:e0233449.
    PubMed     Abstract available


  43. KOZLOVA V, Ledererova A, Ladungova A, Peschelova H, et al
    CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
    PLoS One. 2020;15:e0229170.
    PubMed     Abstract available


  44. ROBERTO G, Spini A, Bartolini C, Moscatelli V, et al
    Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.
    PLoS One. 2020;15:e0229973.
    PubMed     Abstract available


  45. PASQUAL E, Turner MC, Gracia-Lavedan E, Casabonne D, et al
    Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study.
    PLoS One. 2020;15:e0235658.
    PubMed     Abstract available


  46. TERZIEV D, Bauer M, Paschold L, Wickenhauser C, et al
    Impact of bone marrow involvement on outcome in relapsed and refractory transplant eligible diffuse large B-cell lymphoma and transformed indolent lymphoma.
    PLoS One. 2020;15:e0235786.
    PubMed     Abstract available


  47. LEAK SA, Mmbaga LG, Mkwizu EW, Mapendo PJ, et al
    Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
    PLoS One. 2020;15:e0232848.
    PubMed     Abstract available


  48. TSUTSUE S, Tobinai K, Yi J, Crawford B, et al
    Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma.
    PLoS One. 2020;15:e0237509.
    PubMed     Abstract available


  49. SPARKS A, Woods JP, Bienzle D, Wood GA, et al
    Whole genome sequencing analysis of high confidence variants of B-cell lymphoma in Canis familiaris.
    PLoS One. 2020;15:e0238183.
    PubMed     Abstract available


  50. ZOU Q, Zhang H, Meng F, He L, et al
    Proteomic and transcriptomic studies of BGC823 cells stimulated with Helicobacter pylori isolates from gastric MALT lymphoma.
    PLoS One. 2020;15:e0238379.
    PubMed     Abstract available



  51. Retraction: Simultaneous Inhibition of mTOR-Containing Complex 1 (mTORC1) and MNK Induces Apoptosis of Cutaneous T-Cell Lymphoma (CTCL) Cells.
    PLoS One. 2020;15:e0239102.
    PubMed    


  52. KANG HJ, Lee HH, Jung SE, Park KS, et al
    Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    PLoS One. 2020;15:e0238807.
    PubMed     Abstract available


  53. LEE HH, Cho SG, Lee IS, Cho HJ, et al
    Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations.
    PLoS One. 2020;15:e0239740.
    PubMed     Abstract available


  54. WILSON-ROBLES H, Miller T, Jarvis J, Terrell J, et al
    Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer.
    PLoS One. 2020;15:e0236228.
    PubMed     Abstract available


  55. DIRAR Q, Russell T, Liu L, Ahn S, et al
    Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces.
    PLoS One. 2020;15:e0238819.
    PubMed     Abstract available


  56. BOIZA-SANCHEZ M, Manso R, Balague O, Chamizo C, et al
    Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?
    PLoS One. 2020;15:e0241634.
    PubMed     Abstract available


  57. MANYAU MCP, Mudzviti T, Rusakaniko S, Mberi ET, et al
    Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospective study of experiences in Zimbabwe.
    PLoS One. 2020;15:e0239344.
    PubMed     Abstract available


  58. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available


  59. PASQUAL E, Turner MC, Gracia-Lavedan E, Casabonne D, et al
    Correction: Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study.
    PLoS One. 2020;15:e0243396.
    PubMed     Abstract available


  60. KILBRIDE P, Meneghel J, Creasey G, Masoudzadeh F, et al
    Automated dry thawing of cryopreserved haematopoietic cells is not adversely influenced by cryostorage time, patient age or gender.
    PLoS One. 2020;15:e0240310.
    PubMed     Abstract available


  61. TANG L, Chen N, He W, Zhou J, et al
    The clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0240729.
    PubMed     Abstract available


  62. YKEMA BLM, Hoefnagel SJM, Rigter LS, Kodach LL, et al
    Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.
    PLoS One. 2020;15:e0243178.
    PubMed     Abstract available


  63. CHEKOL D, Bedimo M, Mulugeta Y, Bantie GM, et al
    Determinants of non-Hodgkin's lymphoma at Felegehiwot specialized hospital, North West Ethiopia: A case-control study.
    PLoS One. 2020;15:e0243561.
    PubMed     Abstract available


  64. FRIAS S, Van Hummelen P, Meistrich ML, Wyrobek AJ, et al
    Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma.
    PLoS One. 2020;15:e0242218.
    PubMed     Abstract available


  65. THOMOS M, Wurzel P, Scharf S, Koch I, et al
    3D investigation shows walls and wall-like structures around human germinal centres, probably regulating T- and B-cell entry and exit.
    PLoS One. 2020;15:e0242177.
    PubMed     Abstract available


  66. TOGAO O, Chikui T, Tokumori K, Kami Y, et al
    Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
    PLoS One. 2020;15:e0243839.
    PubMed     Abstract available


    January 2019
  67. MELENDEZ-LAZO A, Jasensky AK, Jolly-Frahija IT, Kehl A, et al
    Clonality testing in the lymph nodes from dogs with lymphadenomegaly due to Leishmania infantum infection.
    PLoS One. 2019;14:e0226336.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: